BioCentury

GCase activator reduces α-synuclein in mouse, patient-derived models of PD

Elizabeth S. Eaton
October 24, 2019 5:31 PM UTC

INDICATION: Parkinson's disease (PD) ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Lysosomal Therapeutics Inc.

Northwestern University Feinberg School of Medicine